메뉴 건너뛰기




Volumn 33, Issue 9, 2015, Pages 967-979

A Health Economic Evaluation of Stroke Prevention in Atrial Fibrillation: Guideline Adherence Versus the Observed Treatment Strategy Prior to 2012 in Denmark

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DABIGATRAN; DABIGATRAN ETEXILATE; WARFARIN; ANTICOAGULANT AGENT;

EID: 84941023409     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.1007/s40273-015-0281-z     Document Type: Article
Times cited : (12)

References (58)
  • 1
    • 0025779484 scopus 로고
    • Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
    • COI: 1:STN:280:DyaK3Mzislektg%3D%3D, PID: 1866765
    • Wolf P, Abbott R, Kannel W. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983–8.
    • (1991) Stroke. , vol.22 , pp. 983-988
    • Wolf, P.1    Abbott, R.2    Kannel, W.3
  • 2
    • 80051754505 scopus 로고    scopus 로고
    • Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections
    • PID: 21551478
    • Stefansdottir H, Aspelund T, Gudnason V, Arnar DO. Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace. 2011;13:1110–7.
    • (2011) Europace. , vol.13 , pp. 1110-1117
    • Stefansdottir, H.1    Aspelund, T.2    Gudnason, V.3    Arnar, D.O.4
  • 3
    • 20444395760 scopus 로고    scopus 로고
    • Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study
    • PID: 15879330
    • Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke. 2005;36:1115–9.
    • (2005) Stroke. , vol.36 , pp. 1115-1119
    • Marini, C.1    De Santis, F.2    Sacco, S.3    Russo, T.4    Olivieri, L.5    Totaro, R.6
  • 4
    • 77957738116 scopus 로고    scopus 로고
    • Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
    • PID: 20876603
    • Camm J, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12:1360–420.
    • (2010) Europace. , vol.12 , pp. 1360-1420
    • Camm, J.1    Kirchhof, P.2    Lip, G.Y.H.3    Schotten, U.4    Savelieva, I.5    Ernst, S.6
  • 5
    • 84868523625 scopus 로고    scopus 로고
    • 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association
    • PID: 22922413
    • Camm J, Lip GYH, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33:2719–47.
    • (2012) Eur Heart J. , vol.33 , pp. 2719-2747
    • Camm, J.1    Lip, G.Y.H.2    De Caterina, R.3    Savelieva, I.4    Atar, D.5    Hohnloser, S.H.6
  • 6
    • 34347394385 scopus 로고    scopus 로고
    • Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    • PID: 17577005
    • Hart R, Pearce L, Aguilar M. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857–67.
    • (2007) Ann Intern Med. , vol.146 , pp. 857-867
    • Hart, R.1    Pearce, L.2    Aguilar, M.3
  • 7
    • 84861616750 scopus 로고    scopus 로고
    • Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial
    • COI: 1:CAS:528:DC%2BC38XnslGqtrk%3D, PID: 22492518
    • Hart RG, Diener H-C, Yang S, Connolly SJ, Wallentin L, Reilly PA, et al. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke. 2012;43:1511–7.
    • (2012) Stroke. , vol.43 , pp. 1511-1517
    • Hart, R.G.1    Diener, H.-C.2    Yang, S.3    Connolly, S.J.4    Wallentin, L.5    Reilly, P.A.6
  • 8
    • 84878292470 scopus 로고    scopus 로고
    • Efficacy and safety of dabigatran etexilate and warfarin in “real-world” patients with atrial fibrillation: a prospective nationwide cohort study
    • COI: 1:CAS:528:DC%2BC3sXhtVOrsbrP, PID: 23562920
    • Larsen TB, Rasmussen LH, Skjøth F, Due KM, Callréus T, Rosenzweig M, et al. Efficacy and safety of dabigatran etexilate and warfarin in “real-world” patients with atrial fibrillation: a prospective nationwide cohort study. J Am Coll Cardiol. 2013;61:2264–73.
    • (2013) J Am Coll Cardiol. , vol.61 , pp. 2264-2273
    • Larsen, T.B.1    Rasmussen, L.H.2    Skjøth, F.3    Due, K.M.4    Callréus, T.5    Rosenzweig, M.6
  • 9
    • 84879838346 scopus 로고    scopus 로고
    • Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey
    • PID: 23670894
    • Brandes A, Overgaard M, Plauborg L, Dehlendorff C, Lyck F, Peulicke J, et al. Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey. Clin Cardiol. 2013;36:427–32.
    • (2013) Clin Cardiol. , vol.36 , pp. 427-432
    • Brandes, A.1    Overgaard, M.2    Plauborg, L.3    Dehlendorff, C.4    Lyck, F.5    Peulicke, J.6
  • 10
    • 84878535107 scopus 로고    scopus 로고
    • Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation
    • COI: 1:CAS:528:DC%2BC3sXhtVegu73E, PID: 23640971
    • Wallentin L, Lopes RD, Hanna M, Thomas L, Hellkamp A, Nepal S, et al. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation. 2013;127:2166–76.
    • (2013) Circulation. , vol.127 , pp. 2166-2176
    • Wallentin, L.1    Lopes, R.D.2    Hanna, M.3    Thomas, L.4    Hellkamp, A.5    Nepal, S.6
  • 11
    • 76749163232 scopus 로고    scopus 로고
    • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation
    • PID: 19762550
    • Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263–72.
    • (2010) Chest. , vol.137 , pp. 263-272
    • Lip, G.Y.H.1    Nieuwlaat, R.2    Pisters, R.3    Lane, D.A.4    Crijns, H.J.G.M.5
  • 13
    • 84941026023 scopus 로고    scopus 로고
    • Accessed 29 Dec 2014
    • Danish Council for the Use of Expensive Hospital Medicines. Baggrundsnotat: oral antikoagulationsbehandling ved non-valvulær atrieflimren. 2013. Available at: http://www.regioner.dk/~/media/Mediebibliotek_2011/SUNDHED/Medicin/R%C3%A5det%20for%20Anvendelse%20af%20Dyr%20Sygehusmedicin/Baggrundsnotat%20AF%2020130911%20med%20bilag.ashx. Accessed 29 Dec 2014.
    • (2013) Baggrundsnotat: oral antikoagulationsbehandling ved non-valvulær atrieflimren
  • 15
    • 34249682101 scopus 로고    scopus 로고
    • Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation
    • COI: 1:CAS:528:DC%2BD2sXmtVaqsrc%3D, PID: 17540203
    • Nieuwlaat R, Olsson SB, Lip GYH, Camm J, Breithardt G, Capucci A, et al. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. Am Heart J. 2007;153:1006–12.
    • (2007) Am Heart J. , vol.153 , pp. 1006-1012
    • Nieuwlaat, R.1    Olsson, S.B.2    Lip, G.Y.H.3    Camm, J.4    Breithardt, G.5    Capucci, A.6
  • 16
    • 84995360016 scopus 로고    scopus 로고
    • Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation
    • PID: 16204266
    • Nieuwlaat R, Capucci A, Camm J, Olsson SB, Andresen D, Davies DW, et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J. 2005;26:2422–34.
    • (2005) Eur Heart J. , vol.26 , pp. 2422-2434
    • Nieuwlaat, R.1    Capucci, A.2    Camm, J.3    Olsson, S.B.4    Andresen, D.5    Davies, D.W.6
  • 17
    • 80052426052 scopus 로고    scopus 로고
    • Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a “real world” nationwide cohort study
    • COI: 1:CAS:528:DC%2BC3MXhsVamsrzJ, PID: 21789337
    • Olesen JB, Lip GYH, Lindhardsen J, Lane DA, Ahlehoff O, Hansen ML, et al. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a “real world” nationwide cohort study. Thromb Haemost. 2011;106:739–49.
    • (2011) Thromb Haemost. , vol.106 , pp. 739-749
    • Olesen, J.B.1    Lip, G.Y.H.2    Lindhardsen, J.3    Lane, D.A.4    Ahlehoff, O.5    Hansen, M.L.6
  • 18
    • 84857737421 scopus 로고    scopus 로고
    • Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a “real world” atrial fibrillation population: a modelling analysis based on a nationwide cohort study
    • COI: 1:CAS:528:DC%2BC38XlsVSgtbk%3D, PID: 22186961
    • Banerjee A, Lane DA, Torp-Pedersen C, Lip GYH. Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a “real world” atrial fibrillation population: a modelling analysis based on a nationwide cohort study. Thromb Haemost. 2012;107:584–9.
    • (2012) Thromb Haemost. , vol.107 , pp. 584-589
    • Banerjee, A.1    Lane, D.A.2    Torp-Pedersen, C.3    Lip, G.Y.H.4
  • 19
    • 79955774273 scopus 로고    scopus 로고
    • Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: a Canadian payer perspective
    • COI: 1:CAS:528:DC%2BC3MXns1Sksrc%3D, PID: 21431243
    • Sorensen SV, Kansal AR, Connolly S, Peng S, Linnehan J, Bradley-Kennedy C, et al. Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: a Canadian payer perspective. Thromb Haemost. 2011;105:908–19.
    • (2011) Thromb Haemost. , vol.105 , pp. 908-919
    • Sorensen, S.V.1    Kansal, A.R.2    Connolly, S.3    Peng, S.4    Linnehan, J.5    Bradley-Kennedy, C.6
  • 20
    • 70349306707 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation
    • COI: 1:CAS:528:DC%2BD1MXhtFOjsLnN, PID: 19717844
    • Connolly S, Ezekowitz M. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–51.
    • (2009) N Engl J Med. , vol.361 , pp. 1139-1151
    • Connolly, S.1    Ezekowitz, M.2
  • 21
    • 0042387879 scopus 로고    scopus 로고
    • Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation
    • COI: 1:CAS:528:DC%2BD3sXntlagtbY%3D, PID: 12968085
    • Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med. 2003;349:1019–26.
    • (2003) N Engl J Med. , vol.349 , pp. 1019-1026
    • Hylek, E.M.1    Go, A.S.2    Chang, Y.3    Jensvold, N.G.4    Henault, L.E.5    Selby, J.V.6
  • 22
    • 78649376844 scopus 로고    scopus 로고
    • Intracranial and fatal bleeding according to indication for long-term oral anticoagulant therapy
    • COI: 1:STN:280:DC%2BC3cbis1Wguw%3D%3D, PID: 20723030
    • Linkins L, O’Donnell M, Julian JA, Kearon C. Intracranial and fatal bleeding according to indication for long-term oral anticoagulant therapy. J Thromb Haemost. 2010;8:2201–7.
    • (2010) J Thromb Haemost. , vol.8 , pp. 2201-2207
    • Linkins, L.1    O’Donnell, M.2    Julian, J.A.3    Kearon, C.4
  • 23
    • 84863305471 scopus 로고    scopus 로고
    • Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants
    • COI: 1:CAS:528:DC%2BC38Xpt1Oqurw%3D, PID: 22539546
    • Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, et al. Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants. Stroke. 2012;43:1795–9.
    • (2012) Stroke. , vol.43 , pp. 1795-1799
    • Fang, M.C.1    Go, A.S.2    Chang, Y.3    Borowsky, L.H.4    Pomernacki, N.K.5    Udaltsova, N.6
  • 24
    • 71649099370 scopus 로고    scopus 로고
    • Cost-effectiveness of genotype-guided warfarin dosing for patients with atrial fibrillation
    • PID: 20031873
    • Patrick AR, Avorn J, Choudhry NK. Cost-effectiveness of genotype-guided warfarin dosing for patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2009;2:429–36.
    • (2009) Circ Cardiovasc Qual Outcomes. , vol.2 , pp. 429-436
    • Patrick, A.R.1    Avorn, J.2    Choudhry, N.K.3
  • 25
    • 84899629696 scopus 로고    scopus 로고
    • Real-world” antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey
    • PID: 24486284
    • Lip GYH, Laroche C, Dan G-A, Santini M, Kalarus Z, Rasmussen LH, et al. “Real-world” antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. Am J Med. 2014;127(519–29):e1.
    • (2014) Am J Med. , vol.127 , Issue.519-29 , pp. e1
    • Lip, G.Y.H.1    Laroche, C.2    Dan, G.-A.3    Santini, M.4    Kalarus, Z.5    Rasmussen, L.H.6
  • 26
    • 78649734571 scopus 로고    scopus 로고
    • Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate
    • COI: 1:CAS:528:DC%2BC3MXht1aksrg%3D, PID: 20967400
    • Roskell NS, Lip GYH, Noack H, Clemens A, Plumb JM. Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate. Thromb Haemost. 2010;104:1106–15.
    • (2010) Thromb Haemost. , vol.104 , pp. 1106-1115
    • Roskell, N.S.1    Lip, G.Y.H.2    Noack, H.3    Clemens, A.4    Plumb, J.M.5
  • 28
    • 33847288805 scopus 로고    scopus 로고
    • Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study
    • PID: 17336723
    • Miyasaka Y, Barnes ME, Bailey KR, Cha SS, Gersh BJ, Seward JB, et al. Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol. 2007;49:986–92.
    • (2007) J Am Coll Cardiol. , vol.49 , pp. 986-992
    • Miyasaka, Y.1    Barnes, M.E.2    Bailey, K.R.3    Cha, S.S.4    Gersh, B.J.5    Seward, J.B.6
  • 29
    • 0031686381 scopus 로고    scopus 로고
    • Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials
    • COI: 1:STN:280:DyaK1cvht1Gntw%3D%3D, PID: 9741514
    • Dries DL, Exner DV, Gersh BJ, Hil DP, Domanski MJ, Waclawiw MA, et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Cardiol. 1998;32:695–703.
    • (1998) J Am Coll Cardiol. , vol.32 , pp. 695-703
    • Dries, D.L.1    Exner, D.V.2    Gersh, B.J.3    Hil, D.P.4    Domanski, M.J.5    Waclawiw, M.A.6
  • 30
    • 0034849614 scopus 로고    scopus 로고
    • Atrial fibrillation: a risk factor for increased mortality – an AVID registry analysis
    • COI: 1:STN:280:DC%2BD3MvlsFSnsQ%3D%3D, PID: 11500581
    • Wyse DG, Love JC, Yao Q, Carlson D, Cassidy P, Greene LH, et al. Atrial fibrillation: a risk factor for increased mortality – an AVID registry analysis. J Interv Card Electrophysiol. 2001;5:267–73.
    • (2001) J Interv Card Electrophysiol. , vol.5 , pp. 267-273
    • Wyse, D.G.1    Love, J.C.2    Yao, Q.3    Carlson, D.4    Cassidy, P.5    Greene, L.H.6
  • 31
    • 84941025386 scopus 로고    scopus 로고
    • DOD1: deaths by sex
    • Statistics Denmark. Statistikbanken. DOD1: deaths by sex, age and cause of death. 2014. Available at: http://statistikbanken.dk/dod1. Accessed 29 Dec 2014.
    • (2014) age and cause of death
  • 32
    • 0027167491 scopus 로고
    • Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project
    • COI: 1:STN:280:DyaK3s3otF2rsA%3D%3D, PID: 8506550
    • Dennis MS, Burn JP, Sandercock PA, Bamford JM, Wade DT, Warlow CP. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke. 1993;24:796–800.
    • (1993) Stroke. , vol.24 , pp. 796-800
    • Dennis, M.S.1    Burn, J.P.2    Sandercock, P.A.3    Bamford, J.M.4    Wade, D.T.5    Warlow, C.P.6
  • 34
    • 84941025675 scopus 로고    scopus 로고
    • Consumer price index
    • Statistics Denmark. Statistikbanken. PRIS9: Consumer price index, annual rate of change (inflation) (1900 = 100) by type. 2014. Available at: http://statistikbanken.dk/pris9. Accessed 29 Dec 2014.
    • (2014) annual rate of change (inflation) (1900 = 100) by type
  • 35
    • 84941024387 scopus 로고    scopus 로고
    • Accessed 29 Dec 2014
    • Dansk Lægemiddel Information A/S. 2014. Available at: http://pro.medicin.dk/. Accessed 29 Dec 2014.
    • (2014) Dansk Lægemiddel Information A/S
  • 36
    • 84941024287 scopus 로고    scopus 로고
    • Accessed 29 Dec 2014
    • Danish Medical Association. Table of fees 01-10-2014 [Honorartabel 01-10-2014, Danish]. Available at: http://www.laeger.dk/portal/page/portal/LAEGERDK/Laegerdk/P_L_O/Overenskomster/Honorartabel/Honorartabel%2001-10-2014/Honorartabel%2001-10-2014%20dagtid. Accessed 29 Dec 2014.
    • Table of fees 01-10-2014 [Honorartabel 01-10-2014, Danish]
  • 37
    • 84941023889 scopus 로고    scopus 로고
    • Danish]. 1st ed
    • Pedersen KM. Health economics [Sundhedsøkonomi, Danish]. 1st ed. Copenhagen: Munksgaard; 2013. p. 251.
    • Copenhagen: Munksgaard , vol.2013 , pp. 251
    • Pedersen, K.M.1
  • 38
    • 84941023578 scopus 로고    scopus 로고
    • Cross-sectorial cooperation between general practice and hospital - shared care illustrated by anticoagulant therapy as example: a health technology assessment [Tværsektorielt samarbejde mellem almen praksis og hospital - shared care belyst ved antikoagulansbehandling som eksempel - en Medicinsk Teknologivurdering, Danish]. Copenhagen: MTV-enheden, Aarhus University Hospital
    • Holm T, Lassen JF, Genefke J, Melchiorsen H, Hybel U, Sørensen J. Cross-sectorial cooperation between general practice and hospital - shared care illustrated by anticoagulant therapy as example: a health technology assessment [Tværsektorielt samarbejde mellem almen praksis og hospital - shared care belyst ved antikoagulansbehandling som eksempel - en Medicinsk Teknologivurdering, Danish]. Copenhagen: MTV-enheden, Aarhus University Hospital, The Danish Health and Medicines Authority; 2006.
    • (2006) The Danish Health and Medicines Authority
    • Holm, T.1    Lassen, J.F.2    Genefke, J.3    Melchiorsen, H.4    Hybel, U.5    Sørensen, J.6
  • 41
    • 33749324872 scopus 로고    scopus 로고
    • The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US
    • PID: 17002484
    • Sullivan PW, Arant TW, Ellis SL, Ulrich H. The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US. Pharmacoeconomics. 2006;24:1021–33.
    • (2006) Pharmacoeconomics. , vol.24 , pp. 1021-1033
    • Sullivan, P.W.1    Arant, T.W.2    Ellis, S.L.3    Ulrich, H.4
  • 42
    • 22244440228 scopus 로고    scopus 로고
    • A national catalog of preference-based scores for chronic conditions in the United States
    • PID: 15970790
    • Sullivan PW, Lawrence WF, Ghushchyan V. A national catalog of preference-based scores for chronic conditions in the United States. Med Care. 2005;43:736–49.
    • (2005) Med Care. , vol.43 , pp. 736-749
    • Sullivan, P.W.1    Lawrence, W.F.2    Ghushchyan, V.3
  • 43
    • 84942476127 scopus 로고
    • Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation
    • COI: 1:CAS:528:DyaK28XksFWisg%3D%3D, PID: 7500532
    • Gage BF, Cardinalli AB, Albers GW, Owens DK. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA. 1995;274:1839–45.
    • (1995) JAMA. , vol.274 , pp. 1839-1845
    • Gage, B.F.1    Cardinalli, A.B.2    Albers, G.W.3    Owens, D.K.4
  • 45
    • 84881414199 scopus 로고    scopus 로고
    • Accessed 29 Dec 2014
    • National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal 2013. Available at: http://www.nice.org.uk/media/D45/1E/GuideToMethodsTechnologyAppraisal2013.pdf. Accessed 29 Dec 2014.
    • Guide to the methods of technology appraisal 2013
  • 46
    • 33845718250 scopus 로고    scopus 로고
    • Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation
    • COI: 1:CAS:528:DC%2BD2sXhtFWktrg%3D, PID: 16731536
    • Nieuwlaat R, Capucci A, Lip GYH, Olsson SB, Prins MH, Nieman FH, et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J. 2006;27:3018–26.
    • (2006) Eur Heart J. , vol.27 , pp. 3018-3026
    • Nieuwlaat, R.1    Capucci, A.2    Lip, G.Y.H.3    Olsson, S.B.4    Prins, M.H.5    Nieman, F.H.6
  • 47
    • 84880761205 scopus 로고    scopus 로고
    • Comparative effectiveness of dabigatran, rivaroxaban, apixaban and warfarin in the management of patients with non-valvular atrial fibrillation
    • COI: 1:CAS:528:DC%2BC3sXhtFOju77F, PID: 23619028
    • Pink J, Pirmohamed M, Hughes DA. Comparative effectiveness of dabigatran, rivaroxaban, apixaban and warfarin in the management of patients with non-valvular atrial fibrillation. Clin Pharmacol Ther. 2013;94:269–76.
    • (2013) Clin Pharmacol Ther , vol.94 , pp. 269-276
    • Pink, J.1    Pirmohamed, M.2    Hughes, D.A.3
  • 48
    • 84869202253 scopus 로고    scopus 로고
    • Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis
    • Rasmussen L, Larsen T, Graungaard T, Skjøth F, Lip GYH. Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis. BMJ Open. 2012;7097:1–8.
    • (2012) BMJ Open. , vol.7097 , pp. 1-8
    • Rasmussen, L.1    Larsen, T.2    Graungaard, T.3    Skjøth, F.4    Lip, G.Y.H.5
  • 49
    • 84867124493 scopus 로고    scopus 로고
    • Adjusted indirect comparison of new oral anticoagulants for stroke prevention in atrial fibrillation
    • COI: 1:CAS:528:DC%2BC38XhsVGqurzO, PID: 22771555
    • Testa L, Agnifili M, Latini RA, Mattioli R, Lanotte S, De Marco F, et al. Adjusted indirect comparison of new oral anticoagulants for stroke prevention in atrial fibrillation. QJM. 2012;105:949–57.
    • (2012) QJM. , vol.105 , pp. 949-957
    • Testa, L.1    Agnifili, M.2    Latini, R.A.3    Mattioli, R.4    Lanotte, S.5    De Marco, F.6
  • 50
    • 84893953647 scopus 로고    scopus 로고
    • Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
    • Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2013;6736:1–8.
    • (2013) Lancet. , vol.6736 , pp. 1-8
    • Ruff, C.T.1    Giugliano, R.P.2    Braunwald, E.3    Hoffman, E.B.4    Deenadayalu, N.5    Ezekowitz, M.D.6
  • 51
    • 84891353605 scopus 로고    scopus 로고
    • Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events–European Registry in Atrial Fibrillation (PREFER in AF)
    • PID: 24084680
    • Kirchhof P, Ammentorp B, Darius H, De Caterina R, Le Heuzey J-Y, Schilling RJ, et al. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events–European Registry in Atrial Fibrillation (PREFER in AF). Europace. 2014;16:6–14.
    • (2014) Europace. , vol.16 , pp. 6-14
    • Kirchhof, P.1    Ammentorp, B.2    Darius, H.3    De Caterina, R.4    Le Heuzey, J.-Y.5    Schilling, R.J.6
  • 52
    • 84933503591 scopus 로고    scopus 로고
    • Cost effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control
    • PID: 25512096
    • Janzic A, Kos M. Cost effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control. Pharmacoeconomics. 2015;33(4):395–408.
    • (2015) Pharmacoeconomics. , vol.33 , Issue.4 , pp. 395-408
    • Janzic, A.1    Kos, M.2
  • 53
    • 80054737027 scopus 로고    scopus 로고
    • The business case for quality improvement: oral anticoagulation for atrial fibrillation
    • PID: 21712521
    • Rose A, Berlowitz D, Ash A. The business case for quality improvement: oral anticoagulation for atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2011;4:416–24.
    • (2011) Circ Cardiovasc Qual Outcomes. , vol.4 , pp. 416-424
    • Rose, A.1    Berlowitz, D.2    Ash, A.3
  • 54
    • 67049134013 scopus 로고    scopus 로고
    • Cost-effectiveness of warfarin: trial versus “real-world” stroke prevention in atrial fibrillation
    • PID: 19464418
    • Sorensen SV, Dewilde S, Singer DE, Goldhaber SZ, Monz BU, Plumb JM. Cost-effectiveness of warfarin: trial versus “real-world” stroke prevention in atrial fibrillation. Am Heart J. 2009;157:1064–73.
    • (2009) Am Heart J. , vol.157 , pp. 1064-1073
    • Sorensen, S.V.1    Dewilde, S.2    Singer, D.E.3    Goldhaber, S.Z.4    Monz, B.U.5    Plumb, J.M.6
  • 55
    • 11044231366 scopus 로고    scopus 로고
    • An economic model of stroke in atrial fibrillation: the cost of suboptimal oral anticoagulation
    • PID: 15696909, (discussion S458–61)
    • Caro JJ. An economic model of stroke in atrial fibrillation: the cost of suboptimal oral anticoagulation. Am J Manag Care. 2004;10:S451–8 (discussion S458–61).
    • (2004) Am J Manag Care. , vol.10 , pp. S451-S458
    • Caro, J.J.1
  • 56
    • 84866367284 scopus 로고    scopus 로고
    • Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4
    • PID: 22999131
    • Karnon J, Stahl J, Brennan A, Caro JJ, Mar J, Möller J. Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4. Value Health. 2012;15:821–7.
    • (2012) Value Health. , vol.15 , pp. 821-827
    • Karnon, J.1    Stahl, J.2    Brennan, A.3    Caro, J.J.4    Mar, J.5    Möller, J.6
  • 57
    • 84858753872 scopus 로고    scopus 로고
    • Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable
    • PID: 22221944
    • Coleman CI, Straznitskas AD, Sobieraj DM, Kluger J, Anglade MW. Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable. Am J Cardiol. 2012;109:1020–5.
    • (2012) Am J Cardiol. , vol.109 , pp. 1020-1025
    • Coleman, C.I.1    Straznitskas, A.D.2    Sobieraj, D.M.3    Kluger, J.4    Anglade, M.W.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.